CHAPEL HILL, N.C.--(BUSINESS WIRE)--Nov. 21, 2013--
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to
transforming medicine that transforms lives, announced today that John
R. Plachetka, Pharm.D., the Company’s Chairman, President and Chief
Executive Officer, will present at the Piper Jaffray 25th
Annual Healthcare Conference on Tuesday, December 3, 2013 at 12:30 p.m.
(ET) at the New York Palace Hotel. The presentation will be webcast and
available for replay on POZEN’s home page at www.pozen.com.
POZEN Inc. is a small pharmaceutical company that specializes in
developing novel therapeutics for unmet medical needs and licensing
those products to other pharmaceutical companies for commercialization.
By utilizing a unique in-source model and focusing on integrated
therapies, POZEN has successfully developed and obtained FDA approval of
two self-invented products in two years. Funded by these
milestones/royalty streams, POZEN has created a portfolio of
cost-effective, evidence-based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI damage.
POZEN is currently seeking strategic partners to help maximize the
opportunities for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The
NASDAQ Global Market. For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
Source: POZEN Inc.
Bill Hodges, Chief Financial Officer,
Stephanie Bonestell, Manager,
Investor Relations & Public Relations, 919-913-1030